Regulatory Affairs CROs in Canada
13 published
13 published CROs match Regulatory Affairs in Canada.
Locations in this set include Canada, United States, United Kingdom, India, Poland, and Australia.
Capabilities that show up most often in this set: Small Molecule, Biologics (Other), Gene Therapy, Cell Therapy, and Vaccine.
Matching companies
AltasciencesMid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.
BioPharma Services Inc.Full-service Phase 1 CRO specializing in early-stage clinical trials, bioequivalence/bioavailability studies, and human abuse potential assessments with state-of-the-art facilities in Toronto and in-house bioanalytical labs.
Cadena ResearchCadena Research is a CRO specializing in preclinical development of radiopharmaceuticals, offering laboratory services, radiochemistry expertise, regulatory guidance, and scientific advisory support to accelerate drug development and approval.
CelerionGlobal CRO specializing in early-phase clinical research and bioanalytical sciences with 650+ beds across 30 countries and 50+ years of experience.- JSS Medical ResearchFull-service CRO with over 30 years of experience offering clinical trials, biostatistics, medical writing, and health economics services across all phases of development.
Nucro-TechnicsCanada's largest privately owned CRO specializing in GMP and GLP testing for pharmaceutical, biologic, and medical device companies. Offers analytical chemistry, microbiology, toxicology, bioanalytical, and genetic toxicology services with over 50 years of experience.
Pharma Medica Research Inc.Canadian CRO running early-phase clinical trials from a 24-bed Phase I unit, with in-house bioanalysis under a 21 CFR Part 11-compliant laboratory data management system. Its scientific affairs team supports protocol design, biostatistics, and submission-ready reports.
Premier ResearchPremier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
PrimeVigilancePharmacovigilance and safety services provider offering end-to-end operations, technology-driven solutions, and specialized expertise in vaccines, CGT/ATMP, pediatric medicines, and geriatric populations.
QuanticateQuanticate is a biometrics CRO with 30 years of expertise in biostatistics, clinical data management, and pharmacovigilance across all clinical trial phases. The company specializes in statistical protocol design, CDISC standards compliance, and real-world data analysis to support regulatory submissions.
ResolveMass Laboratories Inc.Canadian CRO and CDMO specializing in polymer synthesis, peptide characterization, and advanced analytical services for drug delivery and pharmaceutical development. FDA-registered and ISO 9001:2015 certified, serving North American pharmaceutical and biotech companies.
Syneos HealthGlobal CRO with 26,000+ employees offering integrated clinical development, regulatory affairs, and commercialization services. Helped develop or commercialize 96% of FDA-approved oncology drugs and 93% of EMA-authorized oncology products in the last five years.
TFS HealthScienceGlobal mid-size CRO specializing in dermatology, internal medicine, neuroscience, oncology, and ophthalmology with Phase I-IV clinical development, real-world evidence studies, and flexible resourcing solutions across 600+ experts in Europe, North America, and Australia.
Markdown mirror: /services/regulatory-affairs/canada.md